Relationship Between Pretreatment Body Composition and Clinical Outcomes in Patients With Metastatic Renal Cell Carcinoma Receiving First-Line Ipilimumab Plus Nivolumab
Hannah D. McManus, Dylan Zhang, Fides R. Schwartz, Yuan Wu, Jordan Infield, Ethan Ho, Andrew J. Armstrong, Daniel J. George, Danielle Kruse, Rajan T. Gupta, Michael R. Harrison
Topics & Concepts
MedicineNivolumabInternal medicineIpilimumabProportional hazards modelHazard ratioRenal cell carcinomaBody mass indexOverweightOncologyCancerGastroenterologyConfidence intervalImmunotherapyRenal cell carcinoma treatmentNutrition and Health in AgingInflammatory Biomarkers in Disease Prognosis